Dogan, MustafaAkbulut, EkremGezdirici, AlperEroz, RecepBozdogan, Sevcan Tug2024-08-232024-08-2320230095-45271934-9440https://doi.org/10.3103/S0095452723040035https://hdl.handle.net/20.500.12684/13854Nonaka myopathy (MIM 605820) is caused by homozygous pathogenic variants in the GNE gene. It is a recessively inherited early adult-onset myopathy that usually preserves the quadriceps and presents with bilateral foot drop, usually caused by anterior tibialis weakness. In patients with Nonaka myopathy, serum creatine kinases are slightly elevated, muscle weakness progresses slowly, and ambulation loss develops after 15-20 yr. The current study aims to raise awareness of Nonaka myopathy that occurs as a rare phenotype due to pathogenic variants in GNE gene. Detailed family histories and clinical data were recorded. Whole exome sequencing was performed and co-segregation analysis of the family were done by Sanger sequencing. Also the homology model of the mutant protein was created with the ProMod3 algorithm. We identified a bialelic pathogenic variant (c.830G>A) in GNE gene, which explain the patients' clinical status. We present the main findings of two siblings with Nonaka myopathy together with detailed clinical and genetic profiles of the patients together with a three-dimensional mutant GNE protein model. We think that the clinical characteristics and the effect of the (c.830G>A) variant will facilitate our understanding of GNE gene in Nonaka myopathy pathogenesis.en10.3103/S0095452723040035info:eu-repo/semantics/closedAccessKeywordsGNE myopathydistal myopathysialic acidNonaka diseaserare diseasesAcetylglucosamine 2-Epimerase/N-Acetylmannosamine KinaseAcid BiosynthesisMutationsExpressionServerWebArticle5743473552-s2.0-85165992668WOS:001037184200007Q4Q4